Africa Dialysis Concentrates and Solutions Market Outlook (2021-2031)

The Africa dialysis concentrates and solutions market size is expected to reach US$ 49.2 million by 2031 from US$ 42.0 million in 2024. The market is estimated to record a CAGR of 2.3% from 2025 to 2031.

Executive Summary and Africa Dialysis Concentrates and Solutions Market Analysis:

The Africa dialysis concentrates and solutions market is poised for substantial growth, driven by rising dialysis sessions, increasing customization of dialysis compositions, and supportive government initiatives in emerging regions. This market represents a significant untapped opportunity, fueled by the escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)—conditions amplified by growing rates of diabetes, hypertension, and ageing populations. Despite strong demand, market expansion faces critical challenges: limited healthcare infrastructure, a shortage of skilled professionals, and inconsistent funding. In most regions, in-center hemodialysis remains the dominant treatment modality due to high costs and a scarcity of dialysis centers, restricting access to a small segment of patients. Egypt stands out with a relatively mature and evolving market, while most sub-Saharan countries remain in the early stages of CKD care development, relying heavily on public-private partnerships to improve access. Demand for consumables linked to in-center treatment will continue to drive growth; however, long-term market evolution hinges on strategic investments in infrastructure, robust public health policies, and initiatives addressing affordability and accessibility barriers.

Africa Dialysis Concentrates and Solutions Market Segmentation Analysis

Key segments that contributed to the derivation of the dialysis concentrates and solutions market analysis are product, application, and end user.

• By product, the dialysis concentrates and solutions market is segmented into acid concentrates, bicarbonate concentrates, powdered concentrates, dialysate, and electrolyte solutions. Acid concentrates dominated the market in 2024, driven by their critical role and high-volume utilization as a core component in hemodialysis—the predominant treatment modality across Africa.
• In terms of application, the market is segmented into hemodialysis and peritoneal dialysis. Hemodialysis accounted for a larger share in 2024, driven by its long-standing position as the primary treatment for end-stage renal disease (ESRD). This dominance is supported by a substantial patient base and well-established, publicly funded clinical infrastructure across multiple countries in Africa.
• By end user, the market is segmented into in-center dialysis settings and home care settings. In-center dialysis dominated the market in 2024, driven by the high prevalence of advanced-stage patients with comorbidities requiring continuous medical supervision. Limited infrastructure and inadequate patient training for home-based care in many parts of the region further reinforce this segment’s leadership.

Africa Dialysis Concentrates and Solutions Market Outlook

The market prospects are set to evolve due to various key trends and strategic developments. There is a clear upward trend towards improving access to healthcare, which is expected to increase the number of dialysis centers, specifically among urban and semi-urban regions. Furthermore, as there is a shift towards more convenience and affordability for the patient, home-based dialysis solutions are gaining interest and acceptance as a viable option, particularly in the case of peritoneal dialysis. This significant market trend could change the concentrates and solutions market. There will be an increase in investment into healthcare by both private and public enterprises, such as partnerships and acquisitions that include product and service development. In addition, there will also be technological innovation in the improvements of dialysis machines and efficient and patient-friendly concentrates. With an increase in the awareness of kidney health and the support of healthcare initiatives and policies, the market is most likely set to continue to grow; however, solving the aspects of affordability in a variety of diabetic or chronic diseases will continue to be time-consuming.

Africa Dialysis Concentrates and Solutions Market Country Insights

Based on country, the Africa dialysis concentrates and solutions market is segmented into Egypt, South Africa, Nigeria, and Algeria. Egypt held the largest share in 2024.

The Africa dialysis concentrates and solutions market exhibits significant variation across countries, shaped by economic strength, healthcare infrastructure, and social dynamics. Mature markets such as Egypt and South Africa benefit from well-established dialysis centers, advanced healthcare systems, and a strong presence of private providers, driving higher adoption of both hemodialysis and peritoneal dialysis. Conversely, emerging markets like Nigeria and Algeria offer substantial growth potential due to large populations and rising CKD prevalence. However, these markets face structural challenges, including pronounced disparities in healthcare access between urban and rural regions. Market development is further influenced by each country’s unique economic conditions, regulatory frameworks, and patient demographics, which collectively determine growth trajectories.

Africa Dialysis Concentrates and Solutions Market Company Profiles

Fresenius Medical Care AG & Co KGaA; Baxter International Inc.; B. Braun SE; Nipro Corp; Medtronic Plc; Nikkiso Co., Ltd; Teleflex Inc; Asahi Kasei Medical Co., Ltd.; Terumo Corp; and DaVita Inc. are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Africa Dialysis Concentrates and Solutions Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Africa Dialysis Concentrates and Solutions Key Sources Referred:

• World Health Organization (WHO)
• United States Renal Data System (USRDS)
• The World Bank Group
• Worldometer
• The Lancet
• International Trade Administration